Physician profile
Donald Peghee
NPI 1235221433
$1,830.65
in general payments reported to CMS, 2019-2025
21 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $575 · 2020: $286 · 2021: $153 · 2022: $442 · 2023: $29.87 · 2024: $224 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $374.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $629.12 | 2019-2023 | |
| Gilead Sciences, INC. | $213.34 | 2019-2022 | |
| Coloplast Corp | $178.83 | 2024 | |
| Gynesonics, INC. | $115.99 | 2022 | |
| Glaxosmithkline, LLC. | $96.25 | 2025 | |
| Pfizer INC. | $89.53 | 2019-2020 | |
| Intuitive Surgical, INC. | $71.07 | 2020 | |
| Daiichi Sankyo INC. | $68.06 | 2019-2020 | |
| Allergan, INC. | $49.91 | 2019-2022 | |
| Exeltis, USA INC. | $48.42 | 2021-2022 | |
| Axonics, INC. | $44.93 | 2022-2023 | Bulkamid |
| Dysis Medical, INC. | $39.61 | 2021-2022 | |
| Organon LLC | $38.92 | 2024-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $38.65 | 2021-2024 | Aptima, Thinprep 2000 Processor |
| Apyx Medical Corporation | $21.50 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $20.85 | 2022 | |
| Minerva Surgical, INC | $17.72 | 2022 | |
| Agile Therapeutics, INC. | $16.96 | 2021 | |
| Medtronic, INC. | $12.24 | 2021 | |
| Boston Scientific Corporation | $10.99 | 2019 | |
| Lifenet Health | $7.76 | 2024 | Theragenesis Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Peghee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.